Patient disposition and treatment group allocation. ∗When once daily (QD) regimens were added to the protocol, QD dosing options were made available to patients receiving once weekly (QW) dosing. ^†Deaths occurring during study treatment were due to pneumonia (2 patients) and intracranial hemorrhage; none attributed to study treatment by the investigator.